Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations
GERMANTOWN, Md., Sept. 8, 2022 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the…
The Galien Foundation Announces 2022 Prix Galien USA Nominees
The Galien Foundation Announces 2022 Prix Galien USA Nominees for "Best Digital Health Solution," "Incubators, Accelerators and Equity," and "Prix Galien Startup" NEW YORK, July 28, 2022 /PRNewswire/ -- The…
Deka Biosciences Breaks Ground on New Facility
GERMANTOWN, Md., July 19, 2022 /PRNewswire/ -- Deka Biosciences announced today that it is breaking ground on a 14,000 square foot office and lab which will house a state of…
Deka Biosciences Raises USD 20 Million in Series A Financing
GERMANTOWN, Md., Nov. 16, 2021 /PRNewswire/ -- Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led…
Deka Biosciences Announces Scientific Advisory Board Members
Germantown, MD (November 4, 2021) – Deka Biosciences is pleased to announce the appointment of six new members to its Scientific Advisory Board: Aurélien Marabelle, MD, PhD (Gustave Roussy), Aung…
In Conversation: John Mumm, Chief Executive Officer, Deka Biosciences speaks with BioBuzz
Dr. John Mumm, CEO of Deka Biosciences, speaks with BioBuzz, sharing how his experience as a young researcher led him to found Deka, a company whose mission is to bring…
Deka Biosciences CEO, Dr. John Mumm, on BioTalk Podcast sharing his views on the region
Deka Biosciences CEO, Dr. John Mumm, on BioTalk Podcast sharing his views on the region, Deka's culture and what it takes to build a successful startup Dr. John Mumm joined…
Next-generation targeted cytokine therapy to be explored on advancements series
JUPITER, Fla., Feb. 27, 2020 /PRNewswire-PRWeb/ -- An upcoming episode of Advancements with Ted Danson, scheduled to broadcast 2Q/2020, will explore innovative treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn's Disease (Crohn's), and Oncology. Check local listings for more info.
